Skip to main content
. 2022 Mar 15;11(1):829–840. doi: 10.1080/22221751.2022.2048969

Figure 5.

Figure 5.

The portion of neutralizing epitopes targeted by booster vaccinations. (a) The portion of neutralizing antibody titre compared to total anti-S + N antibody for I-I-I and I-I-S groups. (b) The portion of neutralizing antibody titre compared to total anti-RBD antibody for I-I-I and I-I-S groups. The portion of neutralizing antibodies represented by monoclonal antibodies 13G2 (c) and 08B3 (d) compared to neutralizing antibody for I-I-I and I-I-S groups at D14 post booster vaccination. n = 20 in I-I-I, n = 25 in I-I-S. ns, not significant; *P < 0.05, ***P < 0.001, ****P < 0.0001.